Expedeon   Report issue

For profit Phase 2
Founded: Harson United Kingdom (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Mergers & Acquisitions

Historical Acquisition Tree